MTOR and neoplasm: By orchestrating signaling cascades, such as AMPK/mTOR, Wnt/β-catenin, and AKT/AMPK, and reprogramming metabolic pathways including glycolysis, lipid metabolism, and the tricarboxylic acid cycle, HKDC1 enhances tumor aggressiveness and chemoresistance.